Marijuana use—whether recreational or therapeutic—is controversial. Although further research is required to definitively determine the impact of marijuana on cardiovascular disease, physicians should use caution in advising or treating any patient with an impaired heart and considerable risk factors.
The legal use of cannabis for either medical or recreational use is growing. Twenty-eight states and the District of Columbia, Guam, and Puerto Rico now have laws legalizing marijuana, and legislatures in several states that recently passed legalization measures are debating regulatory proposals for the use and sale of marijuana. According to the Drug Enforcement Administration (DEA)1 marijuana extract is defined as: “an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant.” Extracts of marijuana will continue to be treated as Schedule I controlled substances.
In response to California’s Proposition 215, the Institute of Medicine issued a report that examined the potential therapeutic uses for marijuana.2 The report found that there is data to support potential therapeutic value of cannabinoid drugs—primarily tetrahydrocannabinol